The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study
Abstract
Background: The effect of specific immunotherapy (SIT) on eczema in atopic dermatitis is not known. Therefore, a multi‐centre, randomized dose–response trial, double‐blind with respect to the efficacy of a biologically standardized depot house dust mite preparation was performed. Methods: Eighty‐nine adults with a chronic course of atopic dermatitis, SCORAD ≥40 and allergic sensitization to house dust mites [CAP‐FEIA ≥3] were included, of whom 51 completed the study. Subcutaneous SIT with a house dust mite preparation (Dermatophagoides pteronyssinus/D. farinae) applying maintenance doses of 20, 2000 and 20 000 SQ‐U in weekly intervals for 1 year. The main outcome measures addressed the change of the SCORAD as average of the values after 9 and 12 months of SIT in comparison with the value at baseline. Results: The SCORAD declined in the three dose groups in a dose‐dependent manner (P = 0.0368, Jonckheere–Terpstra test) and was significantly lower in the two high‐dose groups (2000, 20000 SQ‐U) compared with the low‐dose group of 20 SQ‐U (P = 0.0379, U‐test) after 1 year of SIT. The use of topical corticosteroids was significantly reduced with higher doses (P = 0.0007, Mantel–Haenszel chi‐square test). Conclusions: Allergen‐SIT for 1 year with a house dust mite preparation is able to improve the eczema in patients with atopic dermatitis who are sensitized to house dust mite allergens and reduces the need for topical corticosteroids. SIT may be valuable in the treatment of this chronic skin disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
Grewe, M., Bruijnzeel-Koomen, C. A. F. M., Schöpf, E., Thepen, T., Langeveld-Wildschut, A. G., Ruzicka, T., & Krutmann, J. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01285-7 · Cited by 723
Self-citationBASOPHILS IN ALLERGEN-INDUCED PATCH TEST SITES IN ATOPIC DERMATITIS
Mitchell, E. B., Chapman, M., Pope, F. M., Crow, J., Jouhal, S., & Platts-Mills, T. E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90379-8 · Cited by 416
Sager, N., Feldmann, A., Schilling, G., Kreitsch, P., & Neumann, C. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90434-4 · Cited by 277
Werfel, T., Morita, A., Grewe, M., Renz, H., Wahn, U., Krutmann, J., & Kapp, A. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12331164 · Cited by 217
Self-citationEnvironmental and other major provocation factors in atopic dermatitis
Werfel, T., & Kapp, A. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03968.x · Cited by 131
Self-citationLeroy, B. P., Boden, G., Lachapelle, J. M., Jacquemin, M. G., & Saint-Remy, J.-M. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70033-p · Cited by 72
Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins
Ring, J. (1982) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1982.tb00412.x · Cited by 71
Galli, E., Chini, L., Nardi, S., Benincori, N., Panei, P., Fraioli, G., Moschese, V., & Rossi, P. (1994) · PubMed · Cited by 52
Immunotherapy in atopic dermatitis
Mastrandrea, F. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.1.49 · Cited by 26
Cited by
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,277
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Self-citationMechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Akdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01153.x · Cited by 733
Self-citation
Metadata
- Authors
- Werfel, T., Breuer, K., Ruéff, F., Przybilla, B., Worm, M., Grewe, M., Ruzicka, T., Brehler, R., Wolf, H., Schnitker, J., & Kapp, A.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2006-01-12
- Volume
- 61
- Issue
- 2
- Pages
- 202-205
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2034153343
- Cited by
- 283
- References
- 11
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study. https://app.cochat.ai/papers/10.1111/j.1398-9995.2006.00974.x
- The paper
- Werfel, T., Breuer, K., Ruéff, F., Przybilla, B., Worm, M., Grewe, M., Ruzicka, T., Brehler, R., Wolf, H., Schnitker, J., & Kapp, A. (2006). Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study. Allergy. https://doi.org/10.1111/j.1398-9995.2006.00974.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.